Peptron Stock Price Recovers to 100,000-Won Range... 'Patent Circumvention' and 'Performance Achievement' in Long-Acting Formulation Are Separate Issues
As Peptron's stock price recovered to the 100,000-won range on the 19th, rising 4,000 won to 103,200 won by the morning session, attention is focusing on the difference between the patent claims surrounding its long-acting formulation technology and the actual performance achieved by the product. T

As Peptron's stock price recovered to the 100,000-won range on the 19th, rising 4,000 won to 103,200 won by the morning session, attention is focusing on the difference between the patent claims surrounding its long-acting formulation technology and the actual performance achieved by the product.
The core issue is distinguishing between two matters. First, whether it is possible to design a formulation that circumvents the patent claims by changing the type or combination of polymers. Second, whether such a formulation can achieve the target performance required for an actual product.
■ Drug Release Characteristics Vary Depending on Polymer Conditions
In long-acting formulations, drug release characteristics can vary depending on formulation conditions such as the type and combination of polymers. When polymer conditions change, differences may appear not only in initial release but also in release duration, bioavailability, and pharmacokinetic properties.
Differences based on polymer conditions were also observed in comparative tests described in Peptron's actual patent specification. In cases where specific polymer conditions were changed, results confirmed issues such as excessive initial release or delayed drug release. This demonstrates that the possibility of designing polymer combinations not covered by the patent claims, and whether the target release performance can be achieved through such combinations, are matters that must be examined separately.
■ Hasty Conclusions Are Difficult
Therefore, it is difficult to conclude that the technical significance of this patent is limited based solely on the possibility of using polymer combinations different from the patent claims. Likewise, there is also insufficient basis to conclude that the initial release, release duration, bioavailability, and pharmacokinetic properties required for an actual product can be easily achieved simply by changing the polymer combination.
Ultimately, what needs to be confirmed in this patent is not only the feasibility of designing a formulation outside the scope of the claims, but also whether the target performance can be achieved under the modified polymer conditions.
[This article is for informational purposes regarding investment and does not recommend the purchase or sale of any specific stock. Stock prices may fluctuate depending on market conditions, and the final judgment and responsibility for investments rest with the investor. AI provided partial assistance.]
CBC Globe publishes verified stories with editorial review, source checks, and tenant-specific publication standards.
![[Breaking] Semiconductor Stocks Fall Across the Board on NYSE... Nvidia, Micron, AMD Weaken; SpaceX Rises Over 2%](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F11%2F624560%2Fbc8a6d2c7e02d1bf%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Breaking] New York Stock Market Opens Lower Across the Board... Dow Falls 317 Points, Nasdaq Slightly Down](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F10%2F617544%2F61c0b2bd3bea51f9%2Fvariants%2Fhero.webp&w=1920&q=75)
![[IPO HOT] AL Robot to List on KOSDAQ on the 18th — 'Robot Sensor' Firm Drew 4.41 Trillion Won in Deposits](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F11%2F627776%2F899f189f8b6a1367%2Fvariants%2Fhero.webp&w=1920&q=75)
![[Breaking] US October Retail Sales Rise 6.8% Year-on-Year, 0.2% Month-on-Month... Economic Indicators in Focus After CPI and PPI](/_next/image?url=https%3A%2F%2Fmedia.cbcglobe.com%2Ftenants%2Fcbc00000-0000-4000-8000-000000000001%2Fmedia%2Fcbc%2F2026%2F11%2F627311%2Fa2376e0512277714%2Fvariants%2Fhero.webp&w=1920&q=75)